U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334600) titled 'Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis' on Dec. 30, 2025.
Brief Summary: Seborrheic keratosis is a common benign skin growth that often appears on the face and may cause cosmetic concerns. This study aimed to evaluate the effectiveness and safety of a 1% andaliman fruit extract cream (Zanthoxylum acanthopodium DC.) as a topical treatment for facial seborrheic keratosis.
The study used a one-group pretest-posttest design and involved adult patients with seborrheic keratosis who received the cream for 12 weeks. Changes in lesion size were measured over time, and participants were monitored for side ...